Home › Funds › MILLER HOWARD INVESTMENTS INC /NY › GSK

MILLER HOWARD INVESTMENTS INC /NY position in GSK

GSK PLC · Health Care

MILLER HOWARD INVESTMENTS INC /NY reported holding 1,174,089 shares of GSK (GSK PLC) in its Q3 2026 13F filing — a position valued at US$56.6M, representing 1.54% of its reported portfolio and ranking #26 among its reported holdings. MILLER HOWARD INVESTMENTS INC /NY has disclosed GSK holdings in 8 of the last 8 reported quarters, going back to Q4 2024.

Latest position (Q3 2026)1.17M sh
Reported value held$56.56M
Portfolio Weight1.54%
First reportedQ4 2024
Last changeReduce
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How MILLER HOWARD INVESTMENTS INC /NY's GSK position evolved

MILLER HOWARD INVESTMENTS INC /NY first disclosed a stake in GSK in Q4 2024 at 690,900 shares (US$23.4M). The position peaked in Q1 2026 at 1,629,351 shares, worth US$89.9M. Across 8 filings, MILLER HOWARD INVESTMENTS INC /NY increased the stake 2 time(s), trimmed it 4 time(s) and left it unchanged 1 time(s). The most recent filing (Q3 2026) shows 1,174,089 shares valued at US$56.6M — a reduction of -7,979 shares quarter over quarter.. Notable position changes include a 138% increase in Q1 2025 (shares were roughly flat over the following quarter), a 27% trim in Q2 2026 (shares fell 8% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q4 2024 690.90K $23.37M New
Q1 2025 1.65M $63.80M Add
Q2 2025 1.66M $63.74M Add
Q3 2025 1.66M $71.72M Hold
Q4 2025 1.64M $80.53M Reduce
Q1 2026 1.63M $89.92M Reduce
Q2 2026 1.18M $61.96M Reduce
Q3 2026 1.17M $56.56M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About GSK and 13F data

GSK (GSK PLC) is a Health Care company. 20 other funds we track also report a position in GSK — the largest reported positions include Dodge & Cox (US$2.53B), DODGE & COX (US$2.53B), PRIMECAP MANAGEMENT CO/CA/ (US$1.21B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding GSK

All GSK fund holders →

FAQ

How long has MILLER HOWARD INVESTMENTS INC /NY held GSK?

MILLER HOWARD INVESTMENTS INC /NY has disclosed GSK holdings in 8 of the last 8 reported quarters, going back to Q4 2024.

What is MILLER HOWARD INVESTMENTS INC /NY's current position in GSK?

As of Q3 2026, MILLER HOWARD INVESTMENTS INC /NY holds 1.17M shares of GSK (GSK PLC), valued at $56.56M, representing 1.54% of its reported portfolio and ranking #26.

Has MILLER HOWARD INVESTMENTS INC /NY been buying or selling GSK?

In the latest 13F filing (Q3 2026), MILLER HOWARD INVESTMENTS INC /NY reduced its position in GSK. The position peaked in Q1 2026 at 1.63M shares.

Which other funds hold GSK?

Other major institutional holders of GSK include Dodge & Cox, DODGE & COX, PRIMECAP MANAGEMENT CO/CA/, among 20 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.